A new study published in BMC Gastroenterology identified that patients with inflammatory bowel disease (IBD), such as Crohn's ...

Many China stocks sold off hard Monday after running up since late January. Big losers included Alibaba, Futu Holdings and ...

XPeng reported surging February deliveries vs. a year before. Nio, Li Auto gains were more modest. Tesla rival BYD is on tap.

IBD patients typically start to experience symptoms early in ... Key-Area Research and Development Program of Guangdong Province, China; National Institutes of Health; National Natural Science ...

IBD patients typically start to experience symptoms early in ... Key-Area Research and Development Program of Guangdong ...

Reported positive interim pharmacokinetic ("PK") and safety data in Phase 1 trial of SPY001 in November 2024 and strengthened the balance sheet with a $230 million ...

Ancient DNA traces the Huns' journey from Mongolia to Europe. But this wasn't straightforward.

Based in France, Mathilde Lecoupeur is the Corporate Poultry Vaccination Services Manager for IB and IBD at Ceva. In her role ...

Manufacturing: As a result of FDA approval of RYONCIL in December 2024, the US$23.0 million provision against the value of inventory manufactured and expensed in prior periods was reversed and is now ...

small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis, today ...